Insider Transactions

What Nurix Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	15	43
Total trades	31	101

Shares traded

	3 months	12 months
Acquired	77,743	291,072
Disposed	77,416	273,113
Net activity	+327	+17,959

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Hansen Gwenn	Chief Scientific Officer	Oct 15	Open-market sale · S	−1,452	$25.00	−$36.3K	117,227
Hansen Gwenn	Chief Scientific Officer	Oct 15	Exercise / conversion · M	+1,452	$1.86	+$2.7K	118,679
Gregory Julia P	Director	Oct 14	Open-market sale · S	−22,583	$23.40	−$529K	10,750
Gregory Julia P	Director	Oct 14	Exercise / conversion · M	+22,583	$1.86	+$42K	33,333
Ring Christine	Chief Legal Officer	Oct 02	Open-market sale · S	−5,786	$23.19	−$134K	9,110
Ring Christine	Chief Legal Officer	Oct 02	Exercise / conversion · M	+5,786	$8.72	+$50.5K	14,896
Ring Christine	Chief Legal Officer	Sep 02	Open-market sale · S	−400	$26.64	−$10.7K	9,110
Ring Christine	Chief Legal Officer	Sep 02	Open-market sale · S	−5,387	$25.69	−$138K	9,510
Ring Christine	Chief Legal Officer	Sep 02	Exercise / conversion · M	+5,787	$8.72	+$50.5K	14,897
Hansen Gwenn	Chief Scientific Officer	Sep 01	Open-market sale · S	−1,452	$25.47	−$37K	117,227
Hansen Gwenn	Chief Scientific Officer	Sep 01	Exercise / conversion · M	+1,452	$1.86	+$2.7K	118,679
Hansen Gwenn	Chief Scientific Officer	Aug 05	Open-market sale · S	−4,356	$25.00	−$109K	117,227
Hansen Gwenn	Chief Scientific Officer	Aug 05	Exercise / conversion · M	+4,356	$1.86	+$8.1K	121,583
van Houte Hans	Chief Financial Officer	Aug 04	Open-market sale · S	−2,967	$24.65	−$73.1K	40,166
van Houte Hans	Chief Financial Officer	Aug 04	Open-market sale · S	−1,794	$23.89	−$42.9K	43,133
Hansen Gwenn	Chief Scientific Officer	Aug 04	Open-market sale · S	−2,611	$24.64	−$64.3K	117,227
Hansen Gwenn	Chief Scientific Officer	Aug 04	Open-market sale · S	−1,500	$23.87	−$35.8K	119,838
Ring Christine	Chief Legal Officer	Aug 03	Open-market sale · S	−16,589	$23.05	−$382K	9,110
Ring Christine	Chief Legal Officer	Aug 03	Exercise / conversion · M	+5,787	$8.72	+$50.5K	25,699
Hansen Gwenn	Chief Scientific Officer	Jul 30	Open-market sale · S	−3,847	$23.38	−$90K	121,338

Page 1 of 24 · showing the 20 most recent Sign up free to view all 466 transactions and filter by insider →

Comments